Summary

Eligibility
for males ages 18 years and up (full criteria)
Location
at UCLA
Dates
study started
completion around
Principal Investigator
by Joshua Hyong-Jin Cho (ucla)

Description

Summary

Insomnia is very common, especially in HIV population (up to 73%), and contributes to the development of other conditions such as depression, dementia, inflammation, obesity, and heart diseases. Cognitive-behavioral therapy for insomnia (CBT-I) is known to improve insomnia. However, it has never been tested in HIV-positive patients. The investigators aim to examine the Internet version of this therapy in HIV-positive patients because the availability of CBT-I is very limited while the cost is high. The investigators will test this internet version, also called digital CBT-I (dCBTI), against sleep hygiene education (SHE), a commonly prescribed set of instructions in clinical practice, in 60 HIV-positive patients with insomnia invited from the Multicenter AIDS Cohort Study (MACS) Los Angeles site. The investigators aim to test if dCBTI or SHE improves insomnia in this patient group. This trial involves a behavioral treatment that can be done from home with minimal side effects and includes neither medications nor invasive interventions. Lastly, this trial will provide important pilot data for a larger trial testing long-term effects of insomnia treatment in HIV-positive patients.

Official Title

Pilot Randomized Controlled Trial of Digital Cognitive-Behavioral Therapy for Insomnia in HIV-Infected Individuals

Keywords

Insomnia, Sleep Initiation and Maintenance Disorders, Digital cognitive-behavioral therapy for insomnia (dCBTI), Sleep hygiene education (SHE)

Eligibility

You can join if…

Open to males ages 18 years and up

  • DSM-5 diagnosis of insomnia disorder
  • Aged 18 years or older
  • Reliable Internet access using either computer or smartphone
  • Ability to read and understand English

You CAN'T join if...

Location

  • UCLA Cousins Center for Psychoneuroimmunology
    Los Angeles California 90095 United States

Lead Scientist at University of California Health

  • Joshua Hyong-Jin Cho (ucla)
    HS Clinical Professor, Psychiatry and Biobehavioral Sciences, Medicine. Authored (or co-authored) 48 research publications

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT04308499
Study Type
Interventional
Participants
Expecting 60 study participants
Last Updated